111295-09-1

Basic information

• Product Name: 2-Oxo-3-hydroxy-LSD (2-Oxo-3-hydroxy-lysergic acid diethylamide)
• Synonyms: 2-Oxo-3-hydroxy-LSD (2-Oxo-3-hydroxy-lysergic acid diethylamide);(8β)-9,10-Didehydro-N,N-diethyl-2,3-dihydro-3-hydroxy-6-Methyl-2-oxoergoline-8-carboxaMide;2,3-Dihydro-3-hydroxy-2-oxo Lysergide;N,N-Diethyl-2,3-dihydro-3-hydroxy-2-oxo-lysergaMide;2-Oxo-3-hydroxy-LSD solution;2-Oxo-3-hydroxy-lysergic acid diethylamide solution;(6aR,9R)-N,N-diethyl-5a-hydroxy-7-methyl-5-oxo-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
• CAS NO: 111295-09-1
• Molecular Formula: C20H25N3O3
• Molecular Weight: 355.4308
• EINECS: 200-835-2
• Product Categories: Amines;Heterocycles;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals
• Mol File: 111295-09-1.mol
• Article Data: 2

Chemical Properties

• Flash Point: 2℃
• Appearance: /
• Storage Temp.: ?20°C
• CAS DataBase Reference: 2-Oxo-3-hydroxy-LSD (2-Oxo-3-hydroxy-lysergic acid diethylamide)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Oxo-3-hydroxy-LSD (2-Oxo-3-hydroxy-lysergic acid diethylamide)(111295-09-1)
• EPA Substance Registry System: 2-Oxo-3-hydroxy-LSD (2-Oxo-3-hydroxy-lysergic acid diethylamide)(111295-09-1)

Safety Data

• Hazard Codes: F,Xn
• Statements: 11-20/21/22-36
• Safety Statements: 16-36/37
• RIDADR: UN 1648 3 / PGII
• WGK Germany: 2
• Hazardous Substances Data: 111295-09-1(Hazardous Substances Data)

Usage

Uses

2,3-Dihydro-3-hydroxy-2-oxo Lysergide is a major metabolite of Lysergide (L488010). Controlled Substance.

General Description

2-Oxo-3-hydroxy-LSD is a major urinary metabolite of lysergic acid diethyl amide, or LSD. This certified solution standard is suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, or urine drug testing. Known for its role in 1960′s American counterculture, LSD is one of the most potent psychedelic drugs ever created.

Upstream product

• 50-37-3 lysergide 

Relevant articles and documents

Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay

A general method for the synthesis of OH-LSD and its analogs has been successfully developed. This method is convenient and efficient and allows preparation of a series of OH-LSD analogs with linkers attached at various (C-8, N-6 or N-1) positions.